Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination Full article: Pharmacotherapy for Obesity: Recent Updates Cagrilintide: What It Is and How It's Being Studied for Weight Loss Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination Antiobesity medications in adult and pediatric obesity and metabolic dysfunctionassociated steatotic liver disease Pharmacological Reviews Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48 week phase 2, multicentre, double blind, randomised, placebo controlled trial The Lancet